iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Dermatomyositis

Dermatomyositis

Overview of inflammatory myopathies.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RheumatologyDermatology

Clinical Guidelines

British Society for Rheumatology guideline on management of adult dermatomyositis
National
British Society for Rheumatology guideline on management of juvenile dermatomyositis
National
British Society for Rheumatology guideline on management of adults with idiopathic inflammatory myopathy syndrome including polymyositis and dermatomyositis
Local
Clinical practice guidance for juvenile dermatomyositis (JDM) 2018
Local
Consensus-based recommendations for the management of juvenile dermatomyositis
Local
International Guideline for Idiopathic Inflammatory Myopathy
Local
Updated consensus statement: Intravenous immunoglobulin in the management of neuromuscular disorders
Local

Recent iatroX Q&As

  • What are the recommended referral criteria for a patient suspected of having dermatomyositis?Updated: 8/16/2025
  • How should I approach the management of dermatomyositis in a patient with associated malignancy?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play